Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer | Zendy

Mari. Nikiforova | Zendy; Abigail I. Wald | Zendy; Somak Roy | Zendy; Mary Beth Durso | Zendy; Yuri E. Nikiforov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer

Author(s) -

Mari. Nikiforova,

Abigail I. Wald,

Somak Roy,

Mary Beth Durso,

Yuri E. Nikiforov

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2013-2292

Subject(s) - gnas complex locus , cancer research , thyroid cancer , thyroid carcinoma , cancer , dna sequencing , thyroid nodules , mutation , hras , biology , thyroid , medicine , kras , microbiology and biotechnology , pathology , genetics , gene

Next-generation sequencing (NGS) allows for high-throughput sequencing analysis of large regions of the human genome. We explored the use of targeted NGS for simultaneous testing for multiple mutations in thyroid cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research